News
Harvard Medical School Cancels Student Groups’ Pro-Palestine Vigil
News
Former FTC Chair Lina Khan Urges Democrats to Rethink Federal Agency Function at IOP Forum
News
Cyanobacteria Advisory Expected To Lift Before Head of the Charles Regatta
News
After QuOffice’s Closure, Its Staff Are No Longer Confidential Resources for Students Reporting Sexual Misconduct
News
Harvard Still On Track To Reach Fossil Fuel-Neutral Status by 2026, Sustainability Report Finds
An important breakthrough in cancer research was announced Wednesday. Dr. Richard E. Wilson, associate professor of Surgery, was able to demonstrate the ability of the body's natural antibodies to reject cancer cells.
In August 1964, Wilson transplanted a kidney from a cancer victim to a patient. Then, in January 1966, he discovered that the transplant had induced in his patient the same form of cancer that had killed the kidney donor. Wilson discontinued the use of immunosuppressive drugs which had inhibited the patient's ability to reject the transplant by weakening the antibodies.
The patient's body responded by rejecting both the kidney and the cancer. Subsequently, after the drugs had been recontinued to allow a new operation, the cancer failed to reappear, indicating a complete cure.
The report, written by Wilson and five other doctors, appeared in The New gland Journal of Medicine.
Want to keep up with breaking news? Subscribe to our email newsletter.